City of Hope launches first CAR T cell trial targeting CS1 protein in multiple myeloma

April 26, 2019 | City of Hope

City of Hope is now enrolling relapsed/refractory multiple myeloma patients for a first-of-its kind chimeric antigen receptor T cell therapy phase I trial.

Continue Reading

City of Hope investigates a novel therapeutic approach in AML

April 26, 2019 | City of Hope

City of Hope opens recruitment for a phase I/II dose-finding study of novel agent 8-chloro-adenosine in patients with relapsed/refractory acute myeloid leukemia.

City of Hope launches first CAR T cell trial targeting CS1 protein in multiple myeloma

April 26, 2019 | City of Hope

City of Hope is now enrolling relapsed/refractory multiple myeloma patients for a first-of-its kind chimeric antigen receptor T cell therapy phase I trial.

City of hope innovating how to decrease cmv infections in transplants via novel vaccine approach

February 26, 2019 | City of Hope

Cytomegalovirus (CMV) can cause severe and life-threatening disease in patients undergoing a stem cell or solid organ transplant. City of Hope researchers have been developing a novel vaccine against CMV to decrease the risk of infections in this procedure.

City of hope's bone marrow transplant program reaches two historic milestones

February 26, 2019 | City of Hope

City of Hope’s bone marrow transplant has played a crucial role in the advancement of the procedure that it began doing more than four decades ago.

ASCO’s annual progress against cancer report co-edited by City of Hope physician

January 31, 2019 | Michael Easterling

Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.

New research presented at 60th annual ASH meeting

December 19, 2018 | City of Hope

City of Hope clinical and laboratory investigators presented leading-edge research, including new targets in CAR T cell therapy, at the 60th annual ASH meeting in San Diego.

The Changing Landscape of Lung Cancer Therapy

November 27, 2018 | City of Hope

City of Hope clinical trials reflect the rapidly changing landscape of lung cancer therapy. We continue to pioneer treatment in lung cancer with trials that incorporate biomarker testing and immunotherapy.

CAR T Cell Therapy in Cancer Forum

November 27, 2018 | City of Hope

CAR T cell therapy is one of the most promising new approaches for treating cancer today. Come spend a day learning more about CAR T cell therapy from City of Hope’s resident experts to better understand what is now at the forefront of oncology treatment.

First-of-its-kind CAR T clinical trial enrolls HER2+ breast cancer patients with brain metastases

October 30, 2018 | City of Hope

City of Hope is now enrolling patients in a phase 1 trial evaluating the safety and efficacy of CAR T cell therapy in patients with HER2+ breast cancer that has metastasized to the brain.